Video Upload Options

References

1. Al Tassan N, Khalil D, Shinwari J, Al Sharif L, Bavi P, Abduljaleel Z, AbuDhaim N, Magrashi A, Bobis S, Ahmed H, Alahmed S, Bohlega S. A missense mutation in PIK3R5 gene in a family with ataxia and oculomotor apraxia. Hum Mutat. 2012Feb;33(2):351-4. doi: 10.1002/humu.21650.
2. Anheim M, Monga B, Fleury M, Charles P, Barbot C, Salih M, Delaunoy JP,Fritsch M, Arning L, Synofzik M, Schöls L, Sequeiros J, Goizet C, Marelli C, LeBer I, Koht J, Gazulla J, De Bleecker J, Mukhtar M, Drouot N, Ali-Pacha L,Benhassine T, Chbicheb M, M'Zahem A, Hamri A, Chabrol B, Pouget J, Murphy R,Watanabe M, Coutinho P, Tazir M, Durr A, Brice A, Tranchant C, Koenig M. Ataxiawith oculomotor apraxia type 2: clinical, biological and genotype/phenotypecorrelation study of a cohort of 90 patients. Brain. 2009 Oct;132(Pt 10):2688-98.doi: 10.1093/brain/awp211.
3. Bras J, Alonso I, Barbot C, Costa MM, Darwent L, Orme T, Sequeiros J, Hardy J,Coutinho P, Guerreiro R. Mutations in PNKP cause recessive ataxia with oculomotorapraxia type 4. Am J Hum Genet. 2015 Mar 5;96(3):474-9. doi:10.1016/j.ajhg.2015.01.005.
4. Choudry TN, Hilton-Jones D, Lennox G, Houlden H. Ataxia with oculomotorapraxia type 2: an evolving axonal neuropathy. Pract Neurol. 2018Feb;18(1):52-56. doi: 10.1136/practneurol-2017-001711.
5. Criscuolo C, Chessa L, Di Giandomenico S, Mancini P, Saccà F, Grieco GS, PianeM, Barbieri F, De Michele G, Banfi S, Pierelli F, Rizzuto N, Santorelli FM,Gallosti L, Filla A, Casali C. Ataxia with oculomotor apraxia type 2: a clinical,pathologic, and genetic study. Neurology. 2006 Apr 25;66(8):1207-10.
6. Hoch NC, Hanzlikova H, Rulten SL, Tétreault M, Komulainen E, Ju L, Hornyak P, Zeng Z, Gittens W, Rey SA, Staras K, Mancini GM, McKinnon PJ, Wang ZQ, Wagner JD;Care4Rare Canada Consortium, Yoon G, Caldecott KW. XRCC1 mutation is associatedwith PARP1 hyperactivation and cerebellar ataxia. Nature. 2017 Jan5;541(7635):87-91. doi: 10.1038/nature20790.
7. Le Ber I, Brice A, Dürr A. New autosomal recessive cerebellar ataxias withoculomotor apraxia. Curr Neurol Neurosci Rep. 2005 Sep;5(5):411-7. Review.
8. Le Ber I, Moreira MC, Rivaud-Péchoux S, Chamayou C, Ochsner F, Kuntzer T,Tardieu M, Saïd G, Habert MO, Demarquay G, Tannier C, Beis JM, Brice A, Koenig M,Dürr A. Cerebellar ataxia with oculomotor apraxia type 1: clinical and geneticstudies. Brain. 2003 Dec;126(Pt 12):2761-72.
9. O'Connor E, Vandrovcova J, Bugiardini E, Chelban V, Manole A, Davagnanam I,Wiethoff S, Pittman A, Lynch DS, Efthymiou S, Marino S, Manzur AY, Roberts M,Hanna MG, Houlden H, Matthews E, Wood NW. Mutations in XRCC1 cause cerebellarataxia and peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2018Nov;89(11):1230-1232. doi: 10.1136/jnnp-2017-317581.
10. Renaud M, Moreira MC, Ben Monga B, Rodriguez D, Debs R, Charles P, Chaouch M, Ferrat F, Laurencin C, Vercueil L, Mallaret M, M'Zahem A, Pacha LA, Tazir M,Tilikete C, Ollagnon E, Ochsner F, Kuntzer T, Jung HH, Beis JM, Netter JC,Djamshidian A, Bower M, Bottani A, Walsh R, Murphy S, Reiley T, Bieth É, Roelens F, Poll-The BT, Lourenço CM, Jardim LB, Straussberg R, Landrieu P, Roze E,Thobois S, Pouget J, Guissart C, Goizet C, Dürr A, Tranchant C, Koenig M, Anheim M. Clinical, Biomarker, and Molecular Delineations and Genotype-PhenotypeCorrelations of Ataxia With Oculomotor Apraxia Type 1. JAMA Neurol. 2018 Apr1;75(4):495-502. doi: 10.1001/jamaneurol.2017.4373.